Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycetoma

O Welsh1

  • 1Department of Dermatology, University Hospital, UANL, Monterrey, Mexico.

Seminars in Dermatology
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Mycetoma, a chronic granulomatous disease, requires accurate diagnosis through microscopic identification and agent isolation. Treatment varies, with antibiotics for actinomycetoma and antifungals or surgery for fungal mycetoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leprosy reactions in North-East Mexico: epidemiology and risk factors for chronic erythema nodosum leprosum.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Diaminodiphenyl-sulphone: in vitro activity alone and in combination with other antimicrobials against 30 strains of Nocardia brasiliensis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Image Gallery: Multiple disseminated nodules with dysaesthesia in the Mexican-American border.

The British journal of dermatology·2019
Same author

Evaluation of the Combined Therapy of DA-7218, a New Oxazolidinone, and Trimethoprim/ Sulfamethoxazole in the Treatment of Experimental Actinomycetoma by Nocardia brasiliensis.

Current drug delivery·2010
Same author

In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.

Antimicrobial agents and chemotherapy·2001
Same author

Phospholipase region of Mycobacterium tuberculosis is a preferential locus for IS6110 transposition.

Journal of clinical microbiology·2001

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Dermatology

Background:

  • Mycetoma is a chronic granulomatous infection affecting skin, subcutaneous tissue, bone, and organs.
  • Caused by either bacteria (actinomycetoma) or true fungi (eumycetoma).
  • Diagnosis relies on microscopic identification and isolation of the causative agent.

Purpose of the Study:

  • To outline the diagnostic approaches for mycetoma.
  • To detail current treatment strategies for both actinomycetoma and eumycetoma.
  • To highlight effective therapeutic options for resistant cases.

Main Methods:

  • Microscopic identification of causative agents.
  • Culture and isolation of bacteria or fungi.
  • Clinical assessment of treatment response.

Related Experiment Videos

Main Results:

  • Actinomycetoma treatment involves trimethoprim-sulfamethoxazole and/or diamino-diphenyl-sulfone (DDS).
  • Amikacin is effective in approximately 95% of resistant actinomycetoma cases.
  • Eumycetoma treatment includes amphotericin B, ketoconazole, itraconazole, often combined with surgery.

Conclusions:

  • Effective management of mycetoma depends on accurate etiological diagnosis.
  • Combination therapies and surgical intervention are crucial for certain mycetoma types.
  • Prompt and appropriate treatment can lead to successful patient outcomes.